Filing Details

Accession Number:
0001596771-16-000108
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-02 17:07:11
Reporting Period:
2016-05-02
Filing Date:
2016-05-02
Accepted Time:
2016-05-02 17:07:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610092 Diplomat Pharmacy Inc. DPLO Retail-Drug Stores And Proprietary Stores (5912) 382063100
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619008 A Atheer Kaddis 4100 S. Saginaw Street
Flint MI 48507
Evp Of Sales & Strategic Align No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-02 12,325 $3.07 12,325 No 4 M Direct
Common Stock Disposition 2016-05-02 12,325 $30.17 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option to Acquire Common Stock Disposition 2016-05-02 12,325 $0.00 12,325 $3.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
332,775 2019-04-01 No 4 M Direct
Footnotes
  1. The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 6, 2015. The plan provides for monthly sales of 12,325 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 36,975 shares remain available for sale under the plan, which is set to expire on August 31, 2016.
  2. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $30.00 to $30.38 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable.